Abstract |
A series of 3-nitro-naphthalimides 1(1a-1h) were designed and synthesized as antitumor agents. MTT assay results showed that all these compounds exhibited obvious antiproliferative activity against SKOV3, HepG2, A549, T-24 and SMMC-7721 cancer cell lines, while compound 1a displayed the best antiproliferative activity against HepG2 and T-24 cell lines in comparison with mitonafide, with IC50 of 9.2 ± 1.8 and 4.133 ± 0.9 μM, respectively. In vivo antiproliferative activity assay results showed that compound 1a exhibited good antiproliferative activity in the HepG2 and T-24 models, compared with mitonafide. Action mechanism results showed that compound 1a could induced the damage of DNA and the inhibition topo I, accompanying by inducing the G2-stage arresting and the apoptosis of T-24 cancer cells through up-regulating expression levels of cyclin B1, cdc 2-pTy, Wee1, γH2AX, p21, Bax and cytochrome c and down-regulating expression of Bcl-2.
|
Authors | Mao Xin, Jian-Hua Wei, Chen-Hui Yang, Gui-Bin Liang, Dan Su, Xian-Li Ma, Ye Zhang |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 30
Issue 8
Pg. 127051
(04 15 2020)
ISSN: 1464-3405 [Electronic] England |
PMID | 32111436
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2020 Elsevier Ltd. All rights reserved. |
Chemical References |
- 3-nitro-naphthalimide
- Antineoplastic Agents
- Naphthalimides
|
Topics |
- Animals
- Antineoplastic Agents
(chemical synthesis, chemistry, pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Dose-Response Relationship, Drug
- Drug Design
- Drug Screening Assays, Antitumor
- Humans
- Liver Neoplasms, Experimental
(drug therapy, pathology)
- Mice
- Molecular Structure
- Naphthalimides
(chemistry, pharmacology)
- Structure-Activity Relationship
|